Please ensure Javascript is enabled for purposes of website accessibility

No. 7: Steven Libutti

Health Care Power 50

Libutti is the director of the Rutgers Cancer Institute of New Jersey and vice chancellor for Cancer Programs at Rutgers Biomedical and Health Sciences. In February, the institute announced plans for a new cancer pavilion in New Brunswick that will result in the consolidation of services into a single Cancer Pavilion, and will allow for the consolidation of key cancer services into a single location including laboratory services, an outpatient clinic, infusion/chemotherapy suite, radiation oncology, imaging, and international radiology. Libutti said the landmark facility will create an environment conducive to exceptional patient care and experience, and provide research facilities for groundbreaking discoveries – further enhancing the institute’s role as the state’s only National Cancer Institute-designated Comprehensive Cancer Center. In addition to his leadership roles within Rutgers, Libutti also serves as senior vice president of oncology services for RWJBarnabas Health, a key contact in the university’s partnership with the health care system. He is also a professor of surgery at Rutgers Robert Wood Johnson Medical School and an affiliated distinguished professor in genetics at the Rutgers School of Arts and Sciences Department of Genetics.

Dr. Steven Libutti, Rutgers Cancer Center

Previously, Libutti served as director for the Montefiore Einstein Center for Cancer Care in New York City and was a professor and vice chairman of the Department of Surgery and professor in the Department of Genetics at Albert Einstein College of Medicine and Montefiore Health System. A surgical oncologist, Libutti is an internationally known expert in endocrine surgery and the management of neuroendocrine tumors.

Libutti says the cancer institute offers state-of-the-art science thriving side by side with clinical research and patient care and that his physicians and scientists are leaders in their field. They work diligently to develop new approaches to the detection, treatment and prevention of cancer through groundbreaking clinical, basic, population, and translational research.

As the cancer research hub for New Jersey, the Rutgers Cancer Institute fosters collaborations with New Jersey universities, as well as pharmaceutical and biotechnology companies bringing breakthrough discoveries to patients at a rapid pace. Rutgers Cancer Institute also serves as a valuable resource for New Jersey’s pharmaceutical and biotechnology industries for the development of new cancer treatments.

Write to the Editorial Department at